IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BUGATTI, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.240
EU - Europa 4.134
AS - Asia 2.571
SA - Sud America 468
AF - Africa 74
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.515
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.148
PL - Polonia 2.455
CN - Cina 903
SG - Singapore 803
UA - Ucraina 405
BR - Brasile 390
DE - Germania 292
HK - Hong Kong 256
VN - Vietnam 248
IT - Italia 215
FI - Finlandia 197
GB - Regno Unito 137
FR - Francia 119
TR - Turchia 88
RU - Federazione Russa 84
IE - Irlanda 76
IN - India 73
CA - Canada 56
ID - Indonesia 36
SE - Svezia 28
BD - Bangladesh 27
IQ - Iraq 23
MX - Messico 23
ZA - Sudafrica 23
AR - Argentina 22
AU - Australia 21
CZ - Repubblica Ceca 19
ES - Italia 19
AT - Austria 16
JP - Giappone 16
NL - Olanda 15
EC - Ecuador 12
VE - Venezuela 12
BE - Belgio 11
CL - Cile 10
NG - Nigeria 10
PK - Pakistan 10
SA - Arabia Saudita 10
PE - Perù 9
UZ - Uzbekistan 9
EG - Egitto 8
JO - Giordania 8
KE - Kenya 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 6
EU - Europa 6
LT - Lituania 6
PT - Portogallo 6
AZ - Azerbaigian 5
CH - Svizzera 5
KZ - Kazakistan 5
LK - Sri Lanka 5
OM - Oman 5
TN - Tunisia 5
TW - Taiwan 5
UY - Uruguay 5
BG - Bulgaria 4
CO - Colombia 4
IR - Iran 4
JM - Giamaica 4
MY - Malesia 4
NP - Nepal 4
DK - Danimarca 3
HR - Croazia 3
KG - Kirghizistan 3
KR - Corea 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
PY - Paraguay 3
TH - Thailandia 3
AL - Albania 2
CR - Costa Rica 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
RW - Ruanda 1
SI - Slovenia 1
SV - El Salvador 1
TC - Turks e Caicos 1
ZW - Zimbabwe 1
Totale 12.515
Salva come PNG Salva come JPEG
Città #
Warsaw 2.452
Fairfield 549
Ashburn 508
Singapore 425
Woodbridge 325
Houston 303
Jacksonville 282
Hong Kong 255
Chandler 235
San Jose 225
Cambridge 221
Seattle 215
Beijing 209
Wilmington 195
Ann Arbor 191
Dallas 172
The Dalles 171
New York 146
Princeton 131
Helsinki 122
Los Angeles 105
Dong Ket 87
Nanjing 84
Brescia 77
Dublin 75
Council Bluffs 73
Munich 70
Istanbul 69
Lauterbourg 65
Ho Chi Minh City 58
Jinan 42
Porto Alegre 41
Shanghai 39
Nanchang 37
San Francisco 37
São Paulo 35
Boardman 32
Des Moines 32
Dearborn 30
Changsha 29
San Diego 29
Hebei 28
Shenyang 27
Hanoi 26
Redondo Beach 26
Buffalo 25
Phoenix 25
Jakarta 24
Toronto 24
Chicago 22
Orem 22
Tianjin 22
London 21
Milan 21
Hangzhou 20
Moscow 20
Johannesburg 19
Jiaxing 18
Santa Clara 18
Stockholm 18
Turku 18
Atlanta 17
Guangzhou 16
Brooklyn 15
Manchester 15
Parma 15
Tokyo 15
Brno 14
Denver 14
Lancaster 14
Zhengzhou 14
Montreal 13
Chennai 12
Haikou 12
Boston 11
Charlotte 11
Nuremberg 11
Abuja 10
Frankfurt am Main 10
Rio de Janeiro 10
Verona 10
Amsterdam 9
Lanzhou 9
Mumbai 9
Brussels 8
Kilburn 8
Kunming 8
Salt Lake City 8
Tashkent 8
Vancouver 8
Amman 7
Baghdad 7
Belo Horizonte 7
Curitiba 7
Mexico City 7
Norwalk 7
Taiyuan 7
Augusta 6
Caxias do Sul 6
Erbil 6
Totale 9.323
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 360
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 317
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Epheephrin system 316
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 315
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 311
Biological role of immunoglobulin Free light chains interactomes 306
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 305
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3 301
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 298
Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands 289
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 285
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 281
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 270
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection 259
Pradamicin A: a new therapeutic concept for tretment of virus infections with a glycosilated envelope such as human immunodeficiency virus 256
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 254
A complex of α(6) integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. 246
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice 241
Functionalization of gold surfaces with copoly(DMA-NAS-MAPS) by dip coating: Surface characterization and hybridization tests 231
Chemoselective surface immbolization of proteins through a cleavable peptide 221
The agmatine-containing poly(Amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses 218
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 217
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 213
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 201
Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes 190
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 178
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 176
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 174
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 167
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 165
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 165
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 153
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 153
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 148
Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model. 148
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 147
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 146
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 144
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 142
Plasmonic exosomes for enhanced monitoring of monoclonal gammopathies 135
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 134
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 132
Sulfated K5 Escherichia coli polysaccharide derivatives as wide range inhibitors of genital types of human papillomavirus 131
Surface plasmon resonance analysis of heparin-binding angiogenic growth factors 126
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding Peptide. 123
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 122
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 122
Positively charged peptides can interact with each other as revealed by solid phase binding assays 119
Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule. 118
Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures 117
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 116
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 115
Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses 112
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 112
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 108
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 108
FGF2- Antagonist activity of long pentraxin-3 107
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 105
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 103
FGF2-Antagonist activity of long pentraxin-3 related peptides 103
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 101
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 99
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 87
The NLS of the HIV-1 Tat protein interacts with the fd bacteriophage and with a peptide derived from its p8 protein 86
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 84
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 84
Identification of an anti-angiogenic FGF2-binding site in the n-terminal extension of the soluble pattern recognition receptor long-pentraxin PTX3 80
exploiting surface plasmon resonance technology for the identification of fibroblast growth factor 2 (FGF2) antagonists endowed with antiangiogenic activity 79
inhibition of intra- and extra-cellular Tat function and HIV expression by pertussin toxin B-oligomer 77
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 77
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 74
development of novel small molecules mimicking thrombospondin-1 (TSP-1) antiangiogenic activity 73
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 72
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 71
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 59
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions 46
A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of Concern 21
Molecular mechanisms behind the generation of pro-oncogenic HIV-1 matrix protein p17 variants 15
A broad-spectrum anti-angiogenic tetrapeptide regresses diabetic retinopathy through β-arrestin-1 binding and prevention of Akt phosphorylation 10
Heparan sulfate proteoglycans remodel SARS-CoV-2 spike conformation to allow integrin interaction and infection of endothelial cells 5
Totale 12.675
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.619
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021392 0 0 0 0 0 0 0 0 0 155 114 123
2021/2022627 37 147 15 18 16 15 32 46 33 72 59 137
2022/2023565 75 30 22 35 52 136 2 77 85 3 28 20
2023/2024699 44 10 61 39 42 116 31 27 152 28 31 118
2024/20251.384 15 9 11 226 108 119 78 61 154 136 275 192
2025/20263.155 249 354 340 474 327 242 535 147 202 285 0 0
Totale 12.675